Today, Withings revealed it has acquired approximately $22.5 million in backing as part of a fresh initiative supported by the French government.
Through the France 2030 program, Withings is set to embark on “Project Deep” (
DE
vice as a
H
E
alth
P
revention platform), harnessing state-of-the-art artificial intelligence and medical device innovation. The focus is on enhancing early detection and prevention strategies for cardiometabolic diseases, with the aim of hastening the shift of healthcare systems globally towards digital and preventive measures.
Project DEEP seeks to craft cutting-edge, non-invasive medical tools designed to identify cardiometabolic pathologies at earlier stages. The France 2030 initiative, valued at $56.6 billion, aspires to shape a future for France characterized by sustainability and innovation.
Withings believes Project DEEP marks a significant step in tackling ailments like diabetes, hypertension, atrial fibrillation, and neuropathy. These health issues place considerable pressure on health services, but early detection could mitigate challenges before they evolve into severe complications such as stroke, coronary infarction, and amputations.
The company provides a diverse range of interconnected medical devices, including smart scales, blood pressure monitors, wearable tech, sleep analyzers, and urine analyzers. The integration of AI into this suite allows for scalable, proactive healthcare solutions tailored to individual patient profiles.
“With the increasing burden of cardiometabolic diseases on health systems, embracing tech innovation and AI research becomes crucial for shifting towards a model of preventive care,” stated
Eric Carreel, the chair and founder of Withings.
“France 2030’s backing highlights the significance of enabling French companies like ours to take the global lead in this transformation. Over the forthcoming five years, Project DEEP will drive Withings’ research and development initiatives, enriching our current offerings and setting the stage for pioneering medical technologies and solutions yet to be envisioned.”